NASDAQ:BABY - Natus Medical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$36.05 +0.05 (+0.14 %)
(As of 05/27/2018 04:00 PM ET)
Previous Close$36.05
Today's Range$35.80 - $36.45
52-Week Range$28.00 - $43.60
Volume231,713 shs
Average Volume243,841 shs
Market Capitalization$1.20 billion
P/E Ratio24.86
Dividend YieldN/A
Beta0.49

About Natus Medical (NASDAQ:BABY)

Natus Medical logoNatus Medical Incorporated provides newborn care, neurology, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. It offers diagnostic electroencephalography (EEG), ambulatory EEG, and long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, intra-operative monitoring, and diagnostic and monitoring transcranial doppler ultrasound technology systems. The company also provides hearing screening products to screen the hearing; diagnostic hearing assessment products to screen for or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers. In addition, it offers jaundice management products to treat jaundice; brain injury products to diagnose the severity of brain injury; NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); and essential products used in the everyday operation of NICU. Further, the company provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was founded in 1987 and is headquartered in Pleasanton, California.

Receive BABY News and Ratings via Email

Sign-up to receive the latest news and ratings for BABY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:BABY
CUSIP63905010
Phone925-223-6700

Debt

Debt-to-Equity Ratio0.31
Current Ratio3.06
Quick Ratio2.28

Price-To-Earnings

Trailing P/E Ratio24.86
Forward P/E Ratio22.25
P/E GrowthN/A

Sales & Book Value

Annual Sales$500.97 million
Price / Sales2.40
Cash Flow$2.5104 per share
Price / Cash14.36
Book Value$12.52 per share
Price / Book2.88

Profitability

EPS (Most Recent Fiscal Year)$1.45
Net Income$-20,290,000.00
Net Margins-4.71%
Return on Equity10.96%
Return on Assets6.71%

Miscellaneous

Employees1,726
Outstanding Shares33,300,000

Natus Medical (NASDAQ:BABY) Frequently Asked Questions

What is Natus Medical's stock symbol?

Natus Medical trades on the NASDAQ under the ticker symbol "BABY."

How will Natus Medical's stock buyback program work?

Natus Medical declared that its Board of Directors has authorized a share buyback program on Thursday, February 22nd 2018, which authorizes the company to repurchase $30,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Shares repurchase programs are generally a sign that the company's management believes its stock is undervalued.

How were Natus Medical's earnings last quarter?

Natus Medical Inc (NASDAQ:BABY) posted its quarterly earnings data on Wednesday, April, 25th. The medical equipment provider reported $0.24 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.24. The medical equipment provider earned $128.60 million during the quarter, compared to analysts' expectations of $125.91 million. Natus Medical had a positive return on equity of 10.96% and a negative net margin of 4.71%. The company's quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the business earned $0.30 earnings per share. View Natus Medical's Earnings History.

When is Natus Medical's next earnings date?

Natus Medical is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Natus Medical.

What guidance has Natus Medical issued on next quarter's earnings?

Natus Medical updated its FY18 earnings guidance on Wednesday, April, 25th. The company provided EPS guidance of $1.60-1.65 for the period, compared to the Thomson Reuters consensus estimate of $1.62. The company issued revenue guidance of $535-540 million, compared to the consensus revenue estimate of $536.88 million.Natus Medical also updated its Q2 guidance to $0.25-0.27 EPS.

What price target have analysts set for BABY?

3 analysts have issued twelve-month price objectives for Natus Medical's shares. Their predictions range from $39.00 to $49.00. On average, they anticipate Natus Medical's stock price to reach $44.00 in the next year. View Analyst Ratings for Natus Medical.

Who are some of Natus Medical's key competitors?

Who are Natus Medical's key executives?

Natus Medical's management team includes the folowing people:
  • Mr. James B. Hawkins, Pres, CEO & Director (Age 62)
  • Mr. William M. Moore, Co-Founder & Director (Age 69)
  • Mr. Jonathan A. Kennedy, Exec. VP, CFO, Principal Accounting Officer & GM of Newborn Care (Age 47)
  • Mr. Kenneth M. Traverso, Exec. Officer (Age 57)
  • Dr. D. Christopher Chung, VP of Medical Affairs, Quality & Regulatory Affairs (Age 54)

Has Natus Medical been receiving favorable news coverage?

Media coverage about BABY stock has trended somewhat negative on Sunday, according to Accern Sentiment. The research group identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Natus Medical earned a news sentiment score of -0.19 on Accern's scale. They also assigned media coverage about the medical equipment provider an impact score of 41.11 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

Who are Natus Medical's major shareholders?

Natus Medical's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (13.00%), Silvercrest Asset Management Group LLC (5.10%), Dimensional Fund Advisors LP (4.85%), Impax Asset Management LLC (2.57%), Voce Capital Management LLC (1.98%) and Fisher Asset Management LLC (1.73%). Company insiders that own Natus Medical stock include Dong Chune Christopher Chung, Doris Engibous, James B Hawkins, Jonathan Kennedy, Ken Ludlum, Robert A Gunst and William M Moore. View Institutional Ownership Trends for Natus Medical.

Which institutional investors are selling Natus Medical stock?

BABY stock was sold by a variety of institutional investors in the last quarter, including Lyon Street Capital LLC, Millennium Management LLC, UBS Group AG, WCM Investment Management CA, Mirador Capital Partners LP, Prudential Financial Inc., Fisher Asset Management LLC and Silvercrest Asset Management Group LLC. Company insiders that have sold Natus Medical company stock in the last year include Dong Chune Christopher Chung, James B Hawkins, Ken Ludlum, Robert A Gunst and William M Moore. View Insider Buying and Selling for Natus Medical.

Which institutional investors are buying Natus Medical stock?

BABY stock was acquired by a variety of institutional investors in the last quarter, including Voce Capital Management LLC, Nuveen Asset Management LLC, BlackRock Inc., Eagle Asset Management Inc., Diker Management LLC, Barclays PLC, Wells Fargo & Company MN and Impax Asset Management LLC. View Insider Buying and Selling for Natus Medical.

How do I buy shares of Natus Medical?

Shares of BABY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Natus Medical's stock price today?

One share of BABY stock can currently be purchased for approximately $36.05.

How big of a company is Natus Medical?

Natus Medical has a market capitalization of $1.20 billion and generates $500.97 million in revenue each year. The medical equipment provider earns $-20,290,000.00 in net income (profit) each year or $1.45 on an earnings per share basis. Natus Medical employs 1,726 workers across the globe.

How can I contact Natus Medical?

Natus Medical's mailing address is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. The medical equipment provider can be reached via phone at 925-223-6700 or via email at [email protected]


MarketBeat Community Rating for Natus Medical (BABY)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  193 (Vote Outperform)
Underperform Votes:  198 (Vote Underperform)
Total Votes:  391
MarketBeat's community ratings are surveys of what our community members think about Natus Medical and other stocks. Vote "Outperform" if you believe BABY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BABY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Natus Medical (NASDAQ:BABY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Natus Medical in the last 12 months. Their average twelve-month price target is $44.00, suggesting that the stock has a possible upside of 22.05%. The high price target for BABY is $49.00 and the low price target for BABY is $39.00. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.672.672.502.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $44.00$44.00$49.00$48.00
Price Target Upside: 22.05% upside40.35% upside69.26% upside37.14% upside

Natus Medical (NASDAQ:BABY) Consensus Price Target History

Price Target History for Natus Medical (NASDAQ:BABY)

Natus Medical (NASDAQ:BABY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/27/2018Roth CapitalSet Price TargetBuy ➝ Buy$39.00MediumView Rating Details
1/16/2018BenchmarkReiterated RatingBuy ➝ Buy$55.00 ➝ $49.00LowView Rating Details
1/8/2018William BlairDowngradeOutperform ➝ Market PerformHighView Rating Details
2/2/2017Raymond JamesDowngradeOutperform ➝ Market PerformN/AView Rating Details
2/2/2017UBSDowngradeOutperform ➝ Market PerformN/AView Rating Details
12/16/2016Off Wall StreetInitiated CoverageSellN/AView Rating Details
(Data available from 5/27/2016 forward)

Earnings

Natus Medical (NASDAQ:BABY) Earnings History and Estimates Chart

Earnings by Quarter for Natus Medical (NASDAQ:BABY)

Natus Medical (NASDAQ:BABY) Earnings Estimates

2018 EPS Consensus Estimate: $1.77
2019 EPS Consensus Estimate: $1.84
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.38$0.38$0.38
Q2 20181$0.26$0.26$0.26
Q3 20181$0.53$0.53$0.53
Q4 20181$0.60$0.60$0.60
Q1 20191$0.29$0.29$0.29
Q2 20191$0.40$0.40$0.40
Q3 20191$0.58$0.58$0.58
Q4 20191$0.57$0.57$0.57

Natus Medical (NASDAQ BABY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2018$0.26N/AView Earnings Details
4/25/2018Q1 2018$0.24$0.24$125.91 million$128.60 millionViewN/AView Earnings Details
2/7/2018Q4 2017$0.54$0.42$131.38 million$131.40 millionViewListenView Earnings Details
10/25/2017Q3 2017$0.38$0.40$122.41 million$122.60 millionViewN/AView Earnings Details
7/26/2017Q2 2017$0.33$0.34$121.99 million$122.20 millionViewN/AView Earnings Details
4/26/2017Q1 2017$0.33$0.30$122.45 million$124.70 millionViewN/AView Earnings Details
2/1/2017Q416$0.53$0.51$107.58 million$107.70 millionViewListenView Earnings Details
10/19/2016Q316$0.34$0.39$89.94 million$90.90 millionViewListenView Earnings Details
7/20/2016Q216$0.36$0.39$92.71 million$96.00 millionViewListenView Earnings Details
4/20/2016Q116$0.30$0.34$90.47 million$87.30 millionViewListenView Earnings Details
1/27/2016Q415$0.46$0.51$100.88 million$100.00 millionViewListenView Earnings Details
10/21/2015Q315$0.38$0.39$93.70 million$94.60 millionViewListenView Earnings Details
7/22/2015Q215$0.32$0.34$90.83 million$91.90 millionViewListenView Earnings Details
4/22/2015Q115$0.29$0.31$88.93 million$89.40 millionViewListenView Earnings Details
1/28/2015Q414$0.38$0.40$93.28 million$94.00 millionViewListenView Earnings Details
10/22/2014Q314$0.31$0.33$87.30 million$89.90 millionViewListenView Earnings Details
7/23/2014Q214$0.26$0.28$84.85 million$86.30 millionViewListenView Earnings Details
4/23/2014Q114$0.23$0.26$84.70 million$85.60 millionViewListenView Earnings Details
1/29/2014Q413$0.32$0.37$89.12 million$90.60 millionViewListenView Earnings Details
10/24/2013Q313$0.19$0.30$80.83 million$85.40 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.14$0.21$83.50 million$82.30 millionViewListenView Earnings Details
5/20/2013Q1 2013$0.11$0.15$84.47 million$85.80 millionViewListenView Earnings Details
2/28/2013Q4 2012$0.26$0.29$93.60 million$90.50 millionViewListenView Earnings Details
11/7/2012$0.14$0.15$81.37 million$80.70 millionViewN/AView Earnings Details
7/26/2012$0.11$0.12ViewN/AView Earnings Details
4/26/2012$0.05$0.07ViewN/AView Earnings Details
2/28/2012$0.12$0.14ViewN/AView Earnings Details
10/27/2011$0.06$0.07ViewN/AView Earnings Details
7/28/2011$0.18$0.13ViewN/AView Earnings Details
4/28/2011$0.11$0.13ViewN/AView Earnings Details
3/1/2011Q4 2010$0.22$0.24ViewN/AView Earnings Details
10/28/2010Q3 2010$0.19$0.17ViewN/AView Earnings Details
7/29/2010Q2 2010$0.14$0.15ViewN/AView Earnings Details
4/29/2010Q1 2010$0.03$0.09ViewN/AView Earnings Details
3/4/2010Q4 2009$0.15$0.15ViewN/AView Earnings Details
11/2/2009Q3 2009$0.11$0.14ViewN/AView Earnings Details
7/30/2009Q2 2009$0.05$0.08ViewN/AView Earnings Details
4/30/2009Q1 2009$0.03$0.03ViewN/AView Earnings Details
2/26/2009Q4 2008$0.21$0.22ViewN/AView Earnings Details
10/30/2008Q3 2008$0.18$0.17ViewN/AView Earnings Details
7/31/2008Q2 2008$0.14$0.15ViewN/AView Earnings Details
5/1/2008Q1 2008$0.10$0.11ViewN/AView Earnings Details
2/26/2008Q4 2007$0.18$0.17ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Natus Medical (NASDAQ:BABY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Natus Medical (NASDAQ BABY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.50%
Institutional Ownership Percentage: 89.82%
Insider Trading History for Natus Medical (NASDAQ:BABY)
Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

Natus Medical (NASDAQ BABY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/16/2018William M MooreDirectorSell8,000$35.91$287,280.0030,410View SEC Filing  
5/7/2018Dong Chune Christopher ChungVPSell15,358$33.32$511,728.56151,731View SEC Filing  
4/30/2018James B HawkinsInsiderSell160,000$33.47$5,355,200.00686,757View SEC Filing  
3/2/2018Ken LudlumDirectorSell4,000$31.68$126,720.0093,825View SEC Filing  
11/13/2017William M MooreDirectorSell5,000$41.01$205,050.00View SEC Filing  
11/6/2017Dong Chune Christopher ChungVPSell12,642$42.91$542,468.22141,414View SEC Filing  
9/14/2017Robert A GunstDirectorSell4,400$35.17$154,748.0050,850View SEC Filing  
8/14/2017William M MooreDirectorSell3,000$34.10$102,300.0030,410View SEC Filing  
6/15/2017James B HawkinsInsiderBuy4,000$33.98$135,920.00578,023View SEC Filing  
5/31/2017James B. HawkinsInsiderBuy6,000$33.81$202,860.00View SEC Filing  
5/25/2017Doris EngibousDirectorSell5,000$32.68$163,400.0022,650View SEC Filing  
2/9/2017Robert A GunstDirectorSell5,000$36.00$180,000.0056,150View SEC Filing  
12/16/2016James B HawkinsInsiderBuy10,000$35.20$352,000.00477,396View SEC Filing  
10/27/2016James B HawkinsInsiderBuy10,000$38.30$383,000.00469,725View SEC Filing  
10/25/2016Jonathan KennedyCFOSell30,276$41.40$1,253,426.4091,351View SEC Filing  
10/24/2016Jonathan KennedyCFOSell14,138$41.61$588,282.1891,351View SEC Filing  
10/24/2016Robert A GunstDirectorSell3,250$41.92$136,240.0051,150View SEC Filing  
9/28/2016James B HawkinsInsiderBuy10,000$38.48$384,800.00459,725View SEC Filing  
4/26/2016Robert A GunstDirectorSell5,000$34.61$173,050.0055,000View SEC Filing  
4/22/2016Doris EngibousDirectorSell5,000$32.68$163,400.0018,250View SEC Filing  
4/22/2016Kenneth M TraversoVPSell7,459$33.56$250,324.04112,119View SEC Filing  
2/17/2016Ken LudlumDirectorSell6,625$33.02$218,757.5080,325View SEC Filing  
12/9/2015Dong Chune Christopher ChungVPSell14,000$48.78$682,920.00123,043View SEC Filing  
11/27/2015James B. HawkinsCEOSell57,511$49.09$2,823,214.99377,274View SEC Filing  
11/25/2015Austin Francis Noll IIIVPSell38,875$48.40$1,881,550.0057,934View SEC Filing  
11/12/2015James B. HawkinsCEOSell42,489$47.62$2,023,326.18434,785View SEC Filing  
10/30/2015James B. HawkinsCEOSell100,000$45.75$4,575,000.00477,274View SEC Filing  
10/28/2015Dong Chune Christopher ChungVPSell26,000$45.73$1,188,980.00123,043View SEC Filing  
10/28/2015Jonathan KennedyCFOSell28,958$45.72$1,323,959.7674,000View SEC Filing  
9/15/2015William M MooreDirectorSell5,994$40.76$244,315.4421,910View SEC Filing  
9/14/2015William M MooreDirectorSell4,000$40.27$161,080.0021,910View SEC Filing  
9/8/2015William M MooreDirectorSell3,006$40.09$120,510.5421,910View SEC Filing  
8/18/2015William M MooreDirectorSell3,000$45.62$136,860.0021,910View SEC Filing  
8/13/2015William M MooreDirectorSell4,000$45.55$182,200.00View SEC Filing  
7/24/2015Robert A GunstDirectorSell4,000$45.30$181,200.00View SEC Filing  
6/15/2015William M MooreDirectorSell6,000$41.30$247,800.00View SEC Filing  
6/8/2015James B HawkinsCEOSell100,000$42.08$4,208,000.00View SEC Filing  
6/3/2015Dong Chune Christopher ChungVPSell26,000$41.01$1,066,260.00View SEC Filing  
4/28/2015Kenneth M TraversoVPSell57,233$40.80$2,335,106.40View SEC Filing  
4/24/2015Doris EngibousDirectorSell15,000$42.20$633,000.00View SEC Filing  
2/3/2015Dong Chune Christopher ChungVPSell40,000$36.64$1,465,600.00View SEC Filing  
12/9/2014Jonathan KennedyCFOSell45,833$35.67$1,634,863.11View SEC Filing  
12/8/2014William M MooreDirectorSell4,451$34.65$154,227.15View SEC Filing  
12/5/2014William M MooreDirectorSell561$34.65$19,438.65View SEC Filing  
12/2/2014William M MooreDirectorSell2,278$3,478.00$7,922,884.00View SEC Filing  
11/4/2014James B HawkinsCEOSell18,400$34.10$627,440.00View SEC Filing  
10/30/2014Robert A GunstDirectorSell15,000$33.92$508,800.00View SEC Filing  
10/28/2014Dong Chune Christopher ChungVPSell50,000$33.14$1,657,000.00View SEC Filing  
10/28/2014James B HawkinsCEOSell251,600$33.31$8,380,796.00View SEC Filing  
10/27/2014Dong Chune Christopher ChungVPSell39,521$33.09$1,307,749.89View SEC Filing  
10/24/2014Kenneth M TraversoVPSell30,000$33.33$999,900.00View SEC Filing  
9/10/2014William M MooreDirectorSell2,200$29.30$64,460.00View SEC Filing  
9/8/2014William M MooreDirectorSell5,000$29.17$145,850.00View SEC Filing  
7/30/2014Austin Francis Noll IIIVPSell23,500$29.42$691,370.00View SEC Filing  
5/30/2014Ken LudlumDirectorSell2,500$24.77$61,925.00View SEC Filing  
2/24/2014James HawkinsCEOSell75,000$25.88$1,941,000.00468,844View SEC Filing  
2/13/2014James HawkinsCEOSell96,046$24.77$2,379,059.42468,844View SEC Filing  
2/4/2014James HawkinsCEOSell16,910$25.93$438,476.30468,844View SEC Filing  
12/4/2013James HawkinsCEOSell206,878$22.58$4,671,305.24413,844View SEC Filing  
10/29/2013Kenneth M TraversoVPSell25,000$19.54$488,500.00View SEC Filing  
9/12/2013Doris EngibousDirectorSell33,750$13.53$456,637.506,000View SEC Filing  
9/12/2013Kenneth M TraversoVPSell4,225$13.89$58,685.25View SEC Filing  
8/19/2013Dong Chune Christopher ChungVPSell5,818$12.78$74,354.04120,972View SEC Filing  
8/19/2013James HawkinsCEOSell22,190$12.78$283,588.20413,211View SEC Filing  
6/5/2013Kenneth M TraversoVPSell22,682$14.30$324,352.60View SEC Filing  
6/3/2013Kenneth M TraversoVPSell7,318$14.50$106,111.00View SEC Filing  
5/28/2013Steven J MurphyVPSell10,000$14.42$144,200.00View SEC Filing  
3/12/2013Robert A GunstDirectorBuy5,000$13.40$67,000.00View SEC Filing  
11/27/2012Robert A GunstDirectorBuy10,000$11.66$116,600.00View SEC Filing  
11/9/2012Kenneth M TraversoVPSell49,885$11.19$558,213.15View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Natus Medical (NASDAQ BABY) News Headlines

Source:
DateHeadline
Natus to Present at Jefferies 2018 Healthcare ConferenceNatus to Present at Jefferies 2018 Healthcare Conference
finance.yahoo.com - May 24 at 8:18 AM
Infant Radiant Warmer Market is Expected to Grow at a Faster Rate Owing to the Rapidly Developing Healthcare Infrastructure: Radiant Insights, Inc.Infant Radiant Warmer Market is Expected to Grow at a Faster Rate Owing to the Rapidly Developing Healthcare Infrastructure: Radiant Insights, Inc.
www.bizjournals.com - May 23 at 8:17 AM
Natus Medical Inc (BABY) Expected to Announce Quarterly Sales of $130.61 MillionNatus Medical Inc (BABY) Expected to Announce Quarterly Sales of $130.61 Million
www.americanbankingnews.com - May 23 at 4:14 AM
Natus Medical Inc (BABY) Expected to Post Earnings of $0.26 Per ShareNatus Medical Inc (BABY) Expected to Post Earnings of $0.26 Per Share
www.americanbankingnews.com - May 21 at 5:14 AM
Natus Medical Incorporated (BABY) Director Sells $287,280.00 in StockNatus Medical Incorporated (BABY) Director Sells $287,280.00 in Stock
www.americanbankingnews.com - May 18 at 7:55 PM
Natus Medical Files Definitive Proxy MaterialsNatus Medical Files Definitive Proxy Materials
finance.yahoo.com - May 18 at 8:34 AM
Analyzing Natus Medical (BABY) and EnteroMedics (RSLS)Analyzing Natus Medical (BABY) and EnteroMedics (RSLS)
www.americanbankingnews.com - May 15 at 7:14 PM
Natus Medical (BABY) Upgraded at BidaskClubNatus Medical (BABY) Upgraded at BidaskClub
www.americanbankingnews.com - May 15 at 1:21 PM
Critical Comparison: NxStage (NXTM) and Natus Medical (BABY)Critical Comparison: NxStage (NXTM) and Natus Medical (BABY)
www.americanbankingnews.com - May 13 at 9:09 PM
Natus Medical Incorporated (BABY) Given Average Recommendation of "Hold" by AnalystsNatus Medical Incorporated (BABY) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - May 13 at 9:49 AM
Montco medical center installs NICU camera system to ease parents worriesMontco medical center installs NICU camera system to ease parents' worries
www.bizjournals.com - May 11 at 6:00 PM
Natus Medical Incorporated (BABY) VP Sells $511,728.56 in StockNatus Medical Incorporated (BABY) VP Sells $511,728.56 in Stock
www.americanbankingnews.com - May 9 at 7:55 PM
 Analysts Expect Natus Medical Incorporated (BABY) Will Post Quarterly Sales of $130.61 Million Analysts Expect Natus Medical Incorporated (BABY) Will Post Quarterly Sales of $130.61 Million
www.americanbankingnews.com - May 5 at 2:27 AM
Natus Medical (BABY) Downgraded by ValuEngineNatus Medical (BABY) Downgraded by ValuEngine
www.americanbankingnews.com - May 3 at 11:47 PM
Zacks: Analysts Anticipate Natus Medical Incorporated (BABY) to Post $0.26 Earnings Per ShareZacks: Analysts Anticipate Natus Medical Incorporated (BABY) to Post $0.26 Earnings Per Share
www.americanbankingnews.com - May 3 at 9:25 PM
Natus Medical Incorporated (BABY) Insider James B. Hawkins Sells 160,000 SharesNatus Medical Incorporated (BABY) Insider James B. Hawkins Sells 160,000 Shares
www.americanbankingnews.com - May 2 at 7:22 PM
Report: Developing Opportunities within Natus Medical, Aptevo Therapeutics, Revlon, Silgan, Resources Connection, and TrustCo Bank Corp NY — Future Expectations, Projections Moving into 2018Report: Developing Opportunities within Natus Medical, Aptevo Therapeutics, Revlon, Silgan, Resources Connection, and TrustCo Bank Corp NY — Future Expectations, Projections Moving into 2018
finance.yahoo.com - April 30 at 8:22 AM
William Blair Analysts Reduce Earnings Estimates for Natus Medical Incorporated (BABY)William Blair Analysts Reduce Earnings Estimates for Natus Medical Incorporated (BABY)
www.americanbankingnews.com - April 30 at 2:28 AM
Natus Medical (BABY) Rating Lowered to Hold at BidaskClubNatus Medical (BABY) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - April 28 at 8:34 AM
FY2018 EPS Estimates for Natus Medical Incorporated Increased by William Blair (BABY)FY2018 EPS Estimates for Natus Medical Incorporated Increased by William Blair (BABY)
www.americanbankingnews.com - April 27 at 9:20 AM
Natus Medical: A Tale of Two Halves of the Year?Natus Medical: A Tale of Two Halves of the Year?
finance.yahoo.com - April 26 at 5:18 PM
Edited Transcript of BABY earnings conference call or presentation 25-Apr-18 3:00pm GMTEdited Transcript of BABY earnings conference call or presentation 25-Apr-18 3:00pm GMT
finance.yahoo.com - April 26 at 5:18 PM
Natus Medicals (BABY) CEO Jim Hawkins on Q1 2018 Results - Earnings Call TranscriptNatus Medical's (BABY) CEO Jim Hawkins on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - April 25 at 5:30 PM
Natus Medical (BABY) Issues  Earnings Results, Hits ExpectationsNatus Medical (BABY) Issues Earnings Results, Hits Expectations
www.americanbankingnews.com - April 25 at 12:34 PM
Natus Medical (BABY) Updates FY18 Earnings GuidanceNatus Medical (BABY) Updates FY18 Earnings Guidance
www.americanbankingnews.com - April 25 at 9:40 AM
Natus Medical (BABY) Releases Q2 Earnings GuidanceNatus Medical (BABY) Releases Q2 Earnings Guidance
www.americanbankingnews.com - April 25 at 9:40 AM
Natus Medical EPS in-line, beats on revenueNatus Medical EPS in-line, beats on revenue
seekingalpha.com - April 25 at 8:19 AM
Natus Medical: 1Q Earnings SnapshotNatus Medical: 1Q Earnings Snapshot
finance.yahoo.com - April 25 at 8:19 AM
Natus Medical Announces First Quarter Financial ResultsNatus Medical Announces First Quarter Financial Results
finance.yahoo.com - April 25 at 8:19 AM
BRIEF-Natus Medical Inc Confirms Receipt Of Notice From Voce CapitalBRIEF-Natus Medical Inc Confirms Receipt Of Notice From Voce Capital
www.reuters.com - April 24 at 5:36 PM
Voce Capital Nominates Three Natus DirectorsVoce Capital Nominates Three Natus Directors
www.businesswire.com - April 24 at 8:18 AM
Natus Medical (BABY) Confirms Receipt of Notice of Voce Capital’s Intent to Nominate Director CandidatesNatus Medical (BABY) Confirms Receipt of Notice of Voce Capital’s Intent to Nominate Director Candidates
www.streetinsider.com - April 23 at 5:14 PM
Why Activist Fund Voce Capital Is Seeking to Oust Natus Medicals ChairmanWhy Activist Fund Voce Capital Is Seeking to Oust Natus Medical's Chairman
finance.yahoo.com - April 23 at 5:14 PM
Natus Confirms Receipt of Notice of Voce Capital’s Intent to Nominate Director Candidates to Replace 50% of the Natus BoardNatus Confirms Receipt of Notice of Voce Capital’s Intent to Nominate Director Candidates to Replace 50% of the Natus Board
finance.yahoo.com - April 23 at 5:14 PM
Natus Medical (BABY) Upgraded by BidaskClub to "Buy"Natus Medical (BABY) Upgraded by BidaskClub to "Buy"
www.americanbankingnews.com - April 21 at 7:06 AM
Comparing Natus Medical (BABY) & Zynex (ZYXI)Comparing Natus Medical (BABY) & Zynex (ZYXI)
www.americanbankingnews.com - April 20 at 1:24 PM
Natus Medical Inc (BABY) Given Consensus Recommendation of "Hold" by BrokeragesNatus Medical Inc (BABY) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 18 at 8:33 AM
Natus Medical (BABY) Set to Announce Quarterly Earnings on WednesdayNatus Medical (BABY) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 18 at 3:10 AM
Natus Medical Inc (BABY) Expected to Announce Quarterly Sales of $126.39 MillionNatus Medical Inc (BABY) Expected to Announce Quarterly Sales of $126.39 Million
www.americanbankingnews.com - April 18 at 2:28 AM
 Analysts Anticipate Natus Medical Inc (BABY) to Announce $0.24 Earnings Per Share Analysts Anticipate Natus Medical Inc (BABY) to Announce $0.24 Earnings Per Share
www.americanbankingnews.com - April 16 at 5:14 PM
Natus Medical (BABY) Downgraded by BidaskClubNatus Medical (BABY) Downgraded by BidaskClub
www.americanbankingnews.com - April 14 at 6:22 PM
Zacks Investment Research Upgrades Natus Medical (BABY) to HoldZacks Investment Research Upgrades Natus Medical (BABY) to Hold
www.americanbankingnews.com - April 10 at 8:30 AM
 Analysts Expect Natus Medical Inc (BABY) to Announce $0.24 EPS Analysts Expect Natus Medical Inc (BABY) to Announce $0.24 EPS
www.americanbankingnews.com - March 30 at 9:16 PM
Natus Medical (BABY) Downgraded by William BlairNatus Medical (BABY) Downgraded by William Blair
www.americanbankingnews.com - March 30 at 12:34 PM
Medical Electrodes Market to Grow Rapidly Owing to High Usage in Neonatal ECG, Neurophysiology and Electro ...Medical Electrodes Market to Grow Rapidly Owing to High Usage in Neonatal ECG, Neurophysiology and Electro ...
www.prnewswire.com - March 27 at 5:15 PM
Roth Capital Analysts Give Natus Medical (BABY) a $39.00 Price TargetRoth Capital Analysts Give Natus Medical (BABY) a $39.00 Price Target
www.americanbankingnews.com - March 24 at 8:55 PM
Intraoperative Neuromonitoring Market in the US 2018-2022 with Cadwell, SpecialtyCare, Computational Diagnostics ...Intraoperative Neuromonitoring Market in the US 2018-2022 with Cadwell, SpecialtyCare, Computational Diagnostics ...
www.prnewswire.com - March 24 at 5:16 PM
Natus Medical (BABY) Upgraded by BidaskClub to "Sell"Natus Medical (BABY) Upgraded by BidaskClub to "Sell"
www.americanbankingnews.com - March 24 at 1:10 PM
Natus Medical Inc (BABY) Receives Average Recommendation of "Hold" from AnalystsNatus Medical Inc (BABY) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - March 24 at 10:14 AM
Natus Medical (BABY) is in Overbought Territory: What's Next?Natus Medical (BABY) is in Overbought Territory: What's Next?
finance.yahoo.com - March 22 at 8:23 AM

SEC Filings

Natus Medical (NASDAQ:BABY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Natus Medical (NASDAQ:BABY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Natus Medical (NASDAQ BABY) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.